Md Mahadi Hassan

Md Mahadi Hassan is a Postdoctoral Research Fellow at the University of Maryland, Baltimore (UMB) in the Department of Obstetrics, Gynecology and Reproductive Sciences. Previously, he worked as a Postdoctoral Researcher at Jichi Medical University, Tokyo, Japan (2021–2022), focusing on CRISPR-Cas systems in bacteriophage genetics. His career includes a Quality Control Officer role at Novartis (Bangladesh) Pharmaceutical Limited (2015–2016). He holds a PhD in Clinical Pharmaceutical Sciences from Kumamoto University, Japan (2020).

• Education:
  • B. Pharm (2012), University of Noakhali Science and Technology, Bangladesh
  • M. Pharm (2014), University of Noakhali Science and Technology, Bangladesh
  • PhD (2020), Kumamoto University, Japan

His research spans bacteriophage biology, genetic manipulation, and molecular mechanisms of hyperglycemia-induced birth defects. His work integrates CRISPR-Cas technology with reproductive health studies. Keywords include Natural Product Chemistry, Physical Pharmaceutics, Drug Delivery, Histochemistry, and Congenital Birth Defects.

He has contributed to pharmaceutical sciences and molecular biology with over six years of experience in drug design, bacterial resistance, and phage biology. His current focus at UMB explores intracellular signaling pathways linked to diabetes-induced reproductive dysfunction and birth defects.